From synapse to behavior: Rapid modulation of defined neuronal types with engineered GABAA receptors

Nature Neuroscience

Volumn 10, Issue 7, 2007, Pages 923-929

  Wulff, Peer ^a,f   Goetz, Thomas ^a,f   Leppä, Elli ^b   Linden, Anni Maija ^b   Renzi, Massimiliano ^c   Swinny, Jerome D ^d   Vekovischeva, Olga Y ^b   Sieghart, Werner ^e   Somogyi, Peter ^d   Korpi, Esa R ^b   Farrant, Mark ^c   Wisden, William ^a,f  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e Medical University of Vienna   (Austria)

^f UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; CRE RECOMBINASE; PHENYLALANINE; ZOLPIDEM;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; CELL POPULATION; CEREBELLUM; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SENSITIVITY; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MOTOR DYSFUNCTION; MOUSE; NERVE CELL; NERVE CELL NETWORK; NONHUMAN; PRIORITY JOURNAL; PURKINJE CELL; STATISTICAL SIGNIFICANCE; SYNAPSE; SYNAPTIC INHIBITION; TRANSGENIC MOUSE;

ANIMALS; AUTORADIOGRAPHY; BEHAVIOR, ANIMAL; ELECTROPHYSIOLOGY; FEMALE; GABA AGONISTS; GENOTYPE; GREEN FLUORESCENT PROTEINS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MICE; MICE, KNOCKOUT; MUSCULOSKELETAL EQUILIBRIUM; NEURONS; PATCH-CLAMP TECHNIQUES; PROTEIN ENGINEERING; PURKINJE CELLS; PYRIDINES; RECEPTORS, GABA-A; RECEPTORS, GABA-B; SYNAPSES;

EID: 34347347075     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn1927     Document Type: Article

References (50)

1. Riedel, G. et al. Reversible neural inactivation reveals hippocampal participation in several memory processes. Nat. Neurosci. 2, 898-905 (1999).
2. Lomber, S.G. The advantages and limitations of permanent or reversible deactivation techniques in the assessment of neural function. J. Neurosci. Methods 86, 109-117 (1999).
3. Pereira de Vasconcelos, A. et al. Reversible inactivation of the dorsal hippocampus by tetrodotoxin or lidocaine: a comparative study on cerebral functional activity and motor coordination in the rat. Neuroscience 141, 1649-1663 (2006).
4. Wulff, P. & Wisden, W. Dissecting neural circuitry by combining genetics and pharmacology. Trends Neurosci. 28, 44-50 (2005).
5. Crick, F. The impact of molecular biology on neuroscience. Phil. Trans. R. Soc. Lond. B 354, 2021-2025 (1999).
6. A receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annu. Rev. Pharmacol. Toxicol. 44, 475-498 (2004).
7. A receptors. Nat. Rev. Neurosci. 6, 215-229 (2005).
8. A receptors: a viable target for novel anxiolytics? Curr. Opin. Pharmacol. 6, 24-29 (2006).
9. A receptors in central synapses. J. Neurosci. 19, 578-588 (1999).
10. Thomson, A.M., Bannister, A.P., Hughes, D.I. & Pawelzik, H. Differential sensitivity to Zolpidem of IPSPs activated by morphologically identified CA1 interneurons in slices of rat hippocampus. Eur. J. Neurosci. 12, 425-436 (2000).
11. A receptors. Br. J. Pharmacol. 148, 984-990 (2006).
12. A receptor subtypes. Nature 401, 796-800 (1999).
13. Crestani, F., Martin, J.R., Mohler, H. & Rudolph, U. Mechanism of action of the hypnotic zolpidem in vivo. Br. J. Pharmacol. 131, 1251-1254 (2000).
14. A receptor mutant mouse studies. Nat. Neurosci. 3, 1059 (2000).
15. A receptor α1 subtype. Nat. Neurosci. 3, 587-592 (2000).
16. A receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J. Neurosci. 12, 1040-1062 (1992).
17. A receptors in rat brain. Neuroscience 64, 1113-1128 (1995).
18. 3H]flunitrazepam binding sites. J. Neurochem. 49, 890-899 (1987).
19. A receptors. Mol. Pharmacol. 71, 38-46 (2007).
20. A receptors drastically alter the affinity for ligands of the benzodiazepine binding site. J. Biol. Chem. 272, 11799-11804 (1997).
21. A receptor that determine ligand binding and modulation at the benzodiazepine site. Mol. Pharmacol. 52, 874-881 (1997).
22. A receptor γ2 subunit. Neuropharmacology 47, 17-34 (2004).
23. A receptor γ2 F77I point mutation. Eur. J. Neurosci. 21, 3002-3016 (2005).
24. A receptor γ2 subunit. Biochem. Pharmacol. 68, 1621-1629 (2004).
25. Smeyne, R.J. et al. Local control of granule cell generation by cerebellar Purkinje cells. Mol. Cell. Neurosci. 6, 230-251 (1995).
26. Häusser, M. & Clark, B.A. Tonic synaptic inhibition modulates neuronal output pattern and spatiotemporal synaptic integration. Neuron 19, 665-678 (1997).
27. Mittmann, W., Koch, U. & Häusser, M. Feed-forward inhibition shapes the spike output of cerebellar Purkinje cells. J. Physiol. (Lond.) 563, 369-378 (2005).
28. Santamaria, F., Tripp, P.G. & Bower, J.M. Feed-forward inhibition controls the spread of granule cell-induced Purkinje cell activity in the cerebellar cortex. J. Neurophysiol. 97, 248-263 (2007).
29. A receptor subunit mRNAs in the rat brain. II. Olfactory bulb and cerebellum. J. Neurosci. 12, 1063-1076 (1992).
30. A receptors containing the α1 subunit in Purkinje cells. J. Neurosci. 26, 3245-3255 (2006).
31. Gunther, U. et al. Benzodiazepine-insensitive mice generated by targeted disruption of the γ2 subunit gene of γ-aminobutyric acid type A receptors. Proc. Natl. Acad. Sci. USA 92, 7749-7753 (1995).
32. A receptors is required for maintenance of receptors at mature synapses. Mol. Cell. Neurosci. 24, 442-450 (2003).
33. Barski, J.J., Dethleffsen, K. & Meyer, M. Cre recombinase expression in cerebellar Purkinje cells. Genesis 28, 93-98 (2000).
34. A receptor assembly in mammalian cell lines and hippocampal neurons using γ2 subunit green fluorescent protein chimeras. Mol. Cell. Neurosci. 16, 440-452 (2000).
35. Brickley, S.G., Revilla, V., Cull-Candy, S.G., Wisden, W. & Farrant, M. Adaptive regulation of neuronal excitability by a voltage-independent potassium conductance. Nature 409, 88-92 (2001).
36. Marder, E. & Goaillard, J.M. Variability, compensation and homeostasis in neuron and network function. Nat. Rev. Neurosci. 7, 563-574 (2006).
37. Lima, S.Q. & Miesenbock, G. Remote control of behavior through genetically targeted photostimulation of neurons. Cell 121, 141-152 (2005).
38. Zhang, F. et al. Multimodal fast optical interrogation of neural circuitry. Nature 446, 633-641 (2007).
39. Gosgnach, S. et al. V1 spinal neurons regulate the speed of vertebrate locomotor outputs. Nature 440, 215-219 (2006).
40. Tan, E.M. et al. Selective and quickly reversible inactivation of mammalian neurons in vivo using the Drosophila allatostatin receptor. Neuron 51, 157-170 (2006).
41. Karpova, A.Y., Tervo, D.G., Gray, N.W. & Svoboda, K. Rapid and reversible chemical inactivation of synaptic transmission in genetically targeted neurons. Neuron 48, 727-735 (2005).
42. Yamamoto, M. et al. Reversible suppression of glutamatergic neurotransmission of cerebellar granule cells in vivo by genetically manipulated expression of tetanus neurotoxin light chain. J. Neurosci. 23, 6759-6767 (2003).
43. A receptor-mediated currents in granule cells of postnatal rat cerebellum. Eur. J. Neurosci. 9, 533-548 (1997).
44. A receptors in hippocampal pyramidal neurons exhibit constitutive GABA-independent gating. Mol. Pharmacol. 71, 539-548 (2007).
45. 3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the omega 1 (BZD1) subtype. J. Pharmacol. Exp. Ther. 245, 1033-1041 (1988).
46. A receptor γ2 subunit F77I point-mutated mice. Neuropharmacology 48, 469-478 (2005).
47. Lein, E.S. et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 445, 168-176 (2007).
48. A-benzodiazepine receptor complex by immunoaffinity chromatography. Brain Res. 563, 325-328 (1991).
49. Oertel, W.H., Schmechel, D.E., Mugnaini, E., Tappaz, M.L. & Kopin, I.J. Immunocytochemical localization of glutamate decarboxylase in rat cerebellum with a new antiserum. Neuroscience 6, 2715-2735 (1981).
50. A receptors attenuate benzodiazepine-induced ataxia: evidence from α6-subunit-deficient mice. Eur. J. Neurosci. 11, 233-240 (1999).